Patrick F. Kelly - 13 Apr 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc.

Role: SVP, Chief Medical Officer
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 13 Apr 2022
Net transactions value: +$75,750
Form type: 4
Filing time: 14 Apr 2022, 18:10:41 UTC
Previous filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Options Exercise	$75,750	+15,000	+17%	$5.05	104,884	08 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FMTX	Stock Option (Right to Buy)	Options Exercise	$0	-15,000	-21%	$0.000000	55,134	13 Apr 2022	Common Stock	15,000	$5.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	A total of 70,134 shares subject to an employee stock option were granted on November 21, 2019. 25% of the shares subject to this stock option vested on November 21, 2020, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.